All In MedTech

FDA Clearance Tracker · P160015-S029

AED 3 Defibrillator with Uni-Padz

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 16, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P160015-S029
Device name
AED 3 Defibrillator with Uni-Padz
Applicant location
Chelsmford, MA
Received
Sep 18, 2026
Decided
Oct 16, 2026
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P160015

Device type

Device class
Class III
Regulation
21 CFR 870.5310

Every decision under product code MKJ

FDA's approval statement

As written in FDA's record.

approval of the protocol for the post-approval study (PAS) referenced above to replace the original PAS protocol. The PAS protocol has been submitted to comply with the conditions of approval outlined in the approval order for P160015/S001.

Source documents

Other decisions for ZOLL Medical Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.